Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients (2012)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; TIÉZZI, DANIEL GUIMARÃES - FMRP ; PERIA, FERNANDA MARIS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s12032-010-9793-8
- Subjects: ESTUDOS RETROSPECTIVOS; NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Medical Oncology
- ISSN: 1357-0560
- Volume/Número/Paginação/Ano: v. 29, n. 1, p. 33-38, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BRITO, Luiz Gustavo Oliveira et al. Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients. Medical Oncology, v. 29, n. 1, p. 33-38, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-010-9793-8. Acesso em: 10 jun. 2024. -
APA
Brito, L. G. O., Andrade, J. M. de, Lins-Almeida, T., Zola, F. E., Pinheiro, M. N., Marana, H. R. C., et al. (2012). Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients. Medical Oncology, 29( 1), 33-38. doi:10.1007/s12032-010-9793-8 -
NLM
Brito LGO, Andrade JM de, Lins-Almeida T, Zola FE, Pinheiro MN, Marana HRC, Tiezzi DG, Peria FM. Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients [Internet]. Medical Oncology. 2012 ; 29( 1): 33-38.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s12032-010-9793-8 -
Vancouver
Brito LGO, Andrade JM de, Lins-Almeida T, Zola FE, Pinheiro MN, Marana HRC, Tiezzi DG, Peria FM. Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients [Internet]. Medical Oncology. 2012 ; 29( 1): 33-38.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s12032-010-9793-8 - Breast conserving surgery after neoadjuvant therapy for large primary breast cancer
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Trastuzumab-induced myocardiotoxicity mimicking acute coronary syndrome
- Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens
- Primary adenocarcinoma of the fallopian tube as an incidental finding during surgery in a postmenopausal patient with unspecific pelvic pain
Informações sobre o DOI: 10.1007/s12032-010-9793-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
